The Wolverine Stack (BPC-157 + TB-500): Why This Combo Works
BPC-157 plus TB-500 in a single vial. Why the combination outperforms either alone for injury recovery and systemic repair.
14 min read · Updated June 8, 2026
Quick Answer
The Wolverine Stack is a single compounded vial combining BPC-157 and TB-500 (Thymosin Beta-4). BPC-157 drives local tissue repair and new blood vessel formation; TB-500 promotes systemic cell migration to injury sites. The combination is used as the foundation peptide for injury recovery and systemic repair, and it is prescription-only through a licensed provider and a 503A compounding pharmacy.
A note on evidence before we start: the data behind both peptides is mostly preclinical (animal models) plus consistent anecdotal reports from sports medicine and physique communities. There are no completed human randomized controlled trials of the BPC-157/TB-500 combination. We flag the quality of each claim as we go. Read this as a mechanism-and-protocol explainer, not a promise of a specific outcome.
1. What is the Wolverine Stack?
The Wolverine Stack is the informal name for a combination of two recovery peptides, BPC-157 and TB-500, compounded together into a single vial. The nickname is a community label (a nod to the comic character known for fast healing), not a clinical or regulatory term. It sets an expectation about recovery; it does not describe a proven rate of healing.
At RxPepsDirect, the Wolverine Stack is a prescription product. RxPepsDirect providers write the prescription; Optimal Balance Pharmacy, a licensed 503A compounding pharmacy, prices, fills, ships, and collects payment for the medication. The two parties are distinct: the provider visit and the pharmacy fill are billed separately.
- BPC-157 (Body Protection Compound) is a 15-amino-acid peptide derived from a protein found in gastric juice. It is associated with tissue repair in tendon, ligament, muscle, and the GI tract.
- TB-500 is a synthetic version of the active region of Thymosin Beta-4, the naturally occurring peptide segment responsible for actin binding, cell migration, and wound healing. According to PubMed, that active fragment (LKKTETQ) is what drives the cell-migration and wound-healing effects attributed to TB-500 ( DOI).
Combined in one vial, the stack is positioned as the foundation of injury and recovery protocols: one daily injection covering both a local and a systemic repair mechanism. For full product details, form, and pricing, see the Wolverine Stack product page.
2. Why BPC-157 and TB-500 are complementary (local vs systemic)
The argument for combining these two peptides rather than running one is that they act on different spatial scales. The combination is meant to cover both the injury site and the wider system in a single shot.
- BPC-157 is primarily local. Its strongest documented effects are at the site of injury and injection: promoting new blood vessel formation and upregulating growth factor signaling to rebuild damaged tissue. According to PubMed, in a muscle and tendon healing model BPC-157 modulated angiogenesis by upregulating VEGF expression, producing more adequate healing in treated animals ( DOI for TB-500; BPC-157 angiogenesis source PMID 20388964).
- TB-500 is primarily systemic. Its active region drives cell migration, proliferation, and differentiation, so it is described as circulating to sites of damage throughout the body rather than acting only where it is injected.
In practice that means BPC-157 is the targeted repair agent and TB-500 is the distribution agent. For a single, well-defined injury, BPC-157 alone may be enough. For an athlete carrying several concurrent soft-tissue injuries, post-surgical recovery across a region, or chronic overuse on multiple joints, the combined local-plus-systemic coverage is the rationale for the stack.
Evidence note: this complementary framing is mechanism-based and supported by animal data plus anecdotal reports. There is no human trial directly comparing the combination against either peptide alone.
3. Mechanism: angiogenesis, cell migration, and anti-inflammatory action
Three mechanisms are usually cited for why the stack supports recovery. Here is each one, with an honest read on how strong the underlying evidence is.
- Angiogenesis (new blood vessels). BPC-157 is associated with promoting angiogenesis at injury sites. According to PubMed, immunohistochemical analysis of crushed and transected muscle and tendon showed BPC-157 modulated angiogenesis by up-regulating VEGF, correlating with improved healing (Brcic et al., 2009, rat models). This is animal data, not human data.
- Cell migration. TB-500's active region (LKKTETQ) binds actin and drives cell migration, the process by which repair cells move to damaged tissue. According to PubMed, this actin-binding active site is the basis for TB-500's claimed cell-migration, angiogenesis, and collagen-deposition effects ( DOI).
- Anti-inflammatory effect. Both peptides are described as reducing inflammation at the site of injury, which is part of how they are proposed to shorten recovery. According to PubMed, in an Achilles tendon-to-bone model BPC-157 improved early functional recovery with reduced inflammatory-cell influx and increased new blood vessel formation ( DOI, rat model).
The honest summary: the proposed mechanisms are biologically plausible and consistent across animal studies, but the human evidence is thin. A 2019 review concluded that across two decades of research, BPC-157's effects have been demonstrated mostly in small rodent models and efficacy is yet to be confirmed in humans ( DOI).
4. The single-vial advantage
Combining both peptides into one vial is partly clinical and partly practical.
- One injection instead of two. A single combined vial delivers both peptides in one 20-unit shot, which improves adherence over running two separate vials on overlapping schedules.
- Consistent dosing ratio. The combined formulation fixes the BPC-157-to-TB-500 ratio, so each shot delivers a predictable amount of each peptide rather than relying on the patient to coordinate two products.
- Shipped ready to use. The vial ships pre-reconstituted from Optimal Balance Pharmacy, FedEx overnight, in a reusable cooled travel case. There is no mixing, no bacteriostatic water step, and nothing for the patient to reconstitute.
The trade-off is flexibility: a combined vial locks the ratio, so a patient who wants to titrate one peptide independently would instead run BPC-157 on its own. That is exactly why BPC-157 remains available as a standalone product while TB-500 is offered only inside a combination stack.
5. RxPepsDirect's Wolverine Stack formulation
The RxPepsDirect Wolverine Stack is a combined injectable compounded by Optimal Balance Pharmacy. The specifics:
| Attribute | Detail |
|---|---|
| Peptides | BPC-157 + TB-500 (Thymosin Beta-4) |
| Form | Injectable vial, 5 mL, pre-reconstituted |
| Concentration | 3 mg/mL each (BPC-157 3 mg/mL + TB-500 3 mg/mL) |
| Total per vial | 15 mg BPC-157 + 15 mg TB-500 |
| Starting dose | 20 units (0.6 mg BPC-157 + 0.6 mg TB-500) |
| Beyond-use date | 90 days from compounding (USP <797>) |
| Medication price | $100 per vial, billed by Optimal Balance Pharmacy |
For context within the recovery line: standalone BPC-157 is $80 per 15 mg vial, the Wolverine Stack is $100, the three-peptide BPC-157/TB-500/KPV is $120, and the four-peptide KLOW is $120. Medication pricing is set and collected by Optimal Balance Pharmacy. The RxPepsDirect side is a separate $39 medical visit fee for the provider review and prescription. Two parties, two charges.
On quality claims: certificates of analysis for these compounds cover sterility and endotoxin testing. We do not publish HPLC purity figures, so do not read these specs as a purity claim.
6. Dosing protocol: 20 units daily, Monday to Friday
The standard Wolverine Stack protocol is straightforward, but the exact dose and schedule belong to your prescribing provider.
- Dose: 20 units (0.2 mL) per injection.
- What that delivers: at 3 mg/mL combined, 20 units = 0.2 mL = approximately 0.6 mg BPC-157 + 0.6 mg TB-500 per shot.
- Route: subcutaneous or intramuscular. Some patients inject near the injury site to favor local BPC-157 action; this is a provider-guided choice.
- Frequency: once daily, Monday through Friday, with weekends off. The 5-on, 2-off cadence is the typical loading pattern.
The vial arrives pre-reconstituted, so there is no mixing step. Keep it refrigerated per the pharmacy's instructions. The 90-day beyond-use date is your window once the vial is compounded.
7. When to step up to KLOW
The Wolverine Stack is the foundation. KLOW is the step-up: the same BPC-157 and TB-500 base, plus two more peptides in one vial.
- GHK-Cu (a copper peptide) for collagen and elastin synthesis and skin and connective-tissue support.
- KPV (an alpha-MSH-derived tripeptide) for anti-inflammatory action via NF-kB pathway suppression.
KLOW is the four-peptide combination (BPC-157 / TB-500 / GHK-Cu / KPV) and is positioned for patients who want the recovery base plus added collagen, skin, and stronger anti-inflammatory coverage in a single shot. There is also an intermediate option, BPC-157/TB-500/KPV, which adds only KPV to the Wolverine base. A practical way to think about the ladder:
| Stack | Peptides | Adds over Wolverine | Price |
|---|---|---|---|
| BPC-157 | BPC-157 | Local repair only (single peptide) | $80 |
| Wolverine Stack | BPC-157 + TB-500 | Systemic cell migration | $100 |
| BPC-157/TB-500/KPV | + KPV | Stronger anti-inflammatory | $120 |
| KLOW | + GHK-Cu + KPV | Collagen, skin, anti-inflammatory | $120 |
Which step is right is a provider decision based on your injury profile and goals, not a one-size-fits-all upgrade. Prices reflect the medication cost billed by Optimal Balance Pharmacy.
8. Indications: tendinopathy, post-surgical recovery, chronic injury, intense training
The Wolverine Stack is most commonly used for soft-tissue recovery situations. The clearest supporting evidence is preclinical, so think of these as the contexts where the stack is reached for, with realistic expectations attached.
- Tendinopathy and tendon injury. The strongest animal data sits here. According to PubMed, BPC-157 improved early functional recovery of an Achilles tendon-to-bone unit after transection in rats, with reduced inflammation and increased new blood vessel formation ( DOI).
- Post-surgical recovery. Used to support healing across a recovering region, leaning on TB-500's systemic distribution alongside BPC-157's local repair.
- Chronic and overuse injury. Athletes managing recurring joint or tendon issues from high-volume training are a common user group.
- Intense training load. Used to shorten recovery windows so training can stay consistent. You cannot build or rehab during forced time off, which is the practical case for a recovery peptide.
This stack is a recovery and repair tool. It is not a growth-hormone peptide and does not directly build muscle. If muscle growth is the goal, recovery peptides are a supporting layer alongside the GH peptides covered in our best peptides for muscle growth guide.
9. Cycle length and break protocols
Recovery protocols are typically run as a defined course, not indefinitely. The usual ranges:
- Course length: 4 to 12 weeks is the common window, scaled to the injury. A focused 8-week course for a specific injury, followed by reassessment, is a frequent pattern.
- Loading cadence: the 5-days-on, 2-days-off weekly schedule is the standard during an active course.
- Breaks: after a course, many providers schedule a break to reassess whether the injury has resolved before deciding to continue, switch stacks, or stop.
There is no validated human protocol that fixes an optimal cycle length for the combination, so these are practice patterns rather than evidence-based rules. Your provider sets your course based on response.
10. Side effects and monitoring
Both peptides are generally reported as well tolerated in the available literature and anecdotal use, but the human safety data is limited and long-term human data is essentially absent. Treat the following as what to watch for under provider oversight, not a complete safety profile.
- Injection-site reactions: redness, irritation, or discomfort at the injection site are the most commonly reported effects.
- Active malignancy: because BPC-157 promotes angiogenesis, a history or suspicion of active cancer is a flag that requires provider confirmation before use.
- Autoimmune conditions: these warrant monitoring and provider discussion before starting.
- Pregnancy: not recommended.
- Competitive athletes: TB-500 is monitored in sport. If you compete under an anti-doping body, confirm status before use.
The honest caveat worth repeating: the bulk of the efficacy and safety evidence is from rodent studies. According to PubMed, few studies have reported adverse reactions to BPC-157, but the precise healing mechanism and human safety still need to be established ( DOI). Not everyone responds, and outcomes vary.
11. How to get the Wolverine Stack
The Wolverine Stack is prescription-only. The path is telehealth intake to provider review to pharmacy fill:
- Online intake. Complete a structured health history including injury details, current medications, and cancer history. No in-person visit required.
- Provider review. A licensed RxPepsDirect provider reviews your intake, screens for contraindications, and decides whether the Wolverine Stack (or a different step on the ladder) fits.
- Prescription and fill. The provider sends the prescription to Optimal Balance Pharmacy, the 503A compounding pharmacy. The pharmacy prices, fills, and ships the medication pre-reconstituted, FedEx overnight, in a reusable cooled travel case, and collects payment for the medication.
- Cost structure. A $39 RxPepsDirect medical visit fee covers the provider review and prescription. The medication itself ($100 per vial for the Wolverine Stack) is billed separately by Optimal Balance Pharmacy.
Access is currently limited to 28 U.S. states. Eligibility is confirmed at intake based on your state.
Ready to start?
A $39 provider visit covers your intake review, prescription, and protocol setup. No subscription. The Wolverine Stack medication is priced and filled separately by Optimal Balance Pharmacy.
Start my $39 visit →Keep reading
- → BPC-157 protocol guide, mechanism, evidence limits, and dosing for the standalone peptide
- → Wolverine Stack product page, form, concentration, and pricing
- → Best peptides for muscle growth, where recovery peptides fit alongside GH peptides
- → Recovery and repair catalog, the full ladder from BPC-157 to KLOW
- → Pricing, how the $39 visit fee and medication billing work
Frequently asked questions
- What is the Wolverine Stack?
- The Wolverine Stack is a single compounded vial that combines BPC-157 and TB-500 (Thymosin Beta-4). BPC-157 drives local tissue repair and new blood vessel formation, while TB-500 promotes systemic cell migration to injury sites. It is used as the foundation peptide for injury recovery and is prescription-only through a licensed provider and 503A pharmacy.
- Why is it called the Wolverine Stack?
- The nickname references the comic-book character known for rapid healing. It is an informal community label for the BPC-157 plus TB-500 combination, not a clinical or regulatory term. It reflects user expectations about recovery, not a proven rate of healing.
- Can I take BPC-157 and TB-500 separately?
- Yes, but most providers prescribe them together because their mechanisms are complementary and a single combined vial means one injection instead of two. BPC-157 is also available on its own (injectable or oral capsule). TB-500 is only offered as part of a combination stack, not as a standalone product.
- What is the difference between Wolverine and KLOW?
- The Wolverine Stack is two peptides: BPC-157 and TB-500. KLOW is four peptides in one vial: BPC-157, TB-500, GHK-Cu, and KPV. KLOW adds GHK-Cu for collagen and skin support and KPV for anti-inflammatory action. Wolverine is the foundation; KLOW is the step-up for patients who also want skin, collagen, and stronger anti-inflammatory coverage.
- How long should I run the Wolverine Stack?
- Most recovery protocols run 4 to 12 weeks, with the exact length tied to the injury and the provider's assessment. A common pattern is a focused 8-week course for a specific injury, then a break to reassess. Run length should be set by your prescribing provider, not by a fixed rule.
- Is the Wolverine Stack stronger than BPC-157 alone?
- It is broader rather than simply stronger. BPC-157 acts mainly at the local injection and injury site. Adding TB-500 extends the action systemically, since TB-500's active region drives cell migration throughout the body. For a single localized issue, BPC-157 alone may be sufficient; for multiple or systemic injuries, the combination is the usual choice. Human comparative trials of the two together do not exist, so this is mechanism-based and anecdotal rather than proven head-to-head.
- What injuries does the Wolverine Stack work best for?
- It is most commonly used for tendon and ligament injuries (tendinopathy), post-surgical recovery, chronic overuse injuries, and the cumulative soft-tissue stress of intense training. The strongest published evidence is preclinical (animal tendon and muscle healing models), so expectations should be realistic and any use should be under provider supervision.
- How is the Wolverine Stack dosed?
- The standard protocol is 20 units (0.2 mL) injected subcutaneously or intramuscularly once daily, Monday through Friday. At the 3 mg/mL combined concentration, 20 units delivers about 0.6 mg of BPC-157 plus 0.6 mg of TB-500 per injection. Your provider sets the exact dose and schedule.
Continue reading